Pr. PATRICE CARDE
Oncologue - Hématologue

Parcours

Professeur au Collège de Médecine des Hôpitaux de Paris

Consultant Expert, Département d’Hématologie, Gustave Roussy Cancer Campus, Villejuif

Chef de Service, Oncologie Médicale/Onco-Hématologie, Gustave Roussy Cancer Campus, Villejuif

Former Fellow & Visiting Professor, Medical Oncology Cancer Center, Stanford, California, USA

Chef de Clinique et Interne des Hôpitaux de Paris

Sociétés savantes

President, European Organization on Research and Treatment of Cancer (EORTC) Lymphoma Group

Scientific Secretary, European Organization on Research and Treatment of Cancer (EORTC) Radiotherapy/Chemotherapy Group

Habilitation à Diriger les Recherches (Paris-Sud)

Reviewer, Journal of Clinical Oncology

American Society of Clinical Oncology (ASCO)

American Society of Hematology (ASH)

Société Française d’Hématologie

Publications

[Hodgkin lymphoma: Current and future therapeutic strategies] Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, Patrice Carde

Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives. Corina Cuceu, William M Hempel, Laure Sabatier, Patrice Carde

Reply to C.F. Hess et al. Patrice P Carde, Michael Grynberg, Catherine Poirot, Bengt Glimelius 

Eight Cycles of ABVD Versus Four Cycles of BEACOPP escalated Plus Four Cycles of BEACOPP baseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial, Patrice Carde, Matthias Karrasch, Catherine Fortpied, Pauline Brice

 

Calculer l'itinéraire